232 related articles for article (PubMed ID: 30217285)
1. Staging breast cancer by sentinel lymph node biopsy: Do patients with a single negative sentinel node (N=1) experience worse outcomes than those with multiple negative sentinel nodes (N>1)?
Wilkerson A; Averbook B; Joseph N; Sharpe S; Li B
Surg Oncol; 2018 Sep; 27(3):327-332. PubMed ID: 30217285
[TBL] [Abstract][Full Text] [Related]
2. Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Laws A; Hughes ME; Hu J; Barry WT; Dominici L; Nakhlis F; Barbie T; Duggan M; Weiss A; Rhei E; Carter K; Nimbkar S; Schnitt SJ; King TA
Ann Surg Oncol; 2019 Nov; 26(12):3846-3855. PubMed ID: 31222687
[TBL] [Abstract][Full Text] [Related]
3. Regional Recurrence Risk Following a Negative Sentinel Node Procedure Does Not Approximate the False-Negative Rate of the Sentinel Node Procedure in Breast Cancer Patients Not Receiving Radiotherapy or Systemic Treatment.
Roos MM; van Steenhoven JEC; Aalders KC; Schreuder K; Burgmans JPJ; Siesling S; Elias S; van Dalen T
Ann Surg Oncol; 2019 Feb; 26(2):372-378. PubMed ID: 30387028
[TBL] [Abstract][Full Text] [Related]
4. Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology.
Intra M; Viale G; Vila J; Grana CM; Toesca A; Gentilini O; Galimberti V; Veronesi P; Luini A; Rotmensz N; Bagnardi V; Mattar D; Colleoni M
Ann Surg Oncol; 2015 Jul; 22(7):2372-7. PubMed ID: 25515197
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution.
Gentilini O; Veronesi P; Botteri E; Soggiu F; Trifirò G; Lissidini G; Galimberti V; Musmeci S; Raviele PR; Toesca A; Ratini S; Del Castillo A; Colleoni M; Talakhadze N; Rotmensz N; Viale G; Veronesi U; Luini A
Ann Surg Oncol; 2011 Oct; 18(10):2879-84. PubMed ID: 21479691
[TBL] [Abstract][Full Text] [Related]
6. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
7. Disease recurrence in sentinel node-positive breast cancer patients forgoing axillary lymph node dissection.
Cyr A; Gao F; Gillanders WE; Aft RL; Eberlein TJ; Margenthaler JA
Ann Surg Oncol; 2012 Oct; 19(10):3185-91. PubMed ID: 22890591
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
9. Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients.
Canavese G; Tinterri C; Carli F; Garrone E; Spinaci S; Della Valle A; Barbieri E; Marrazzo E; Bruzzi P; Dozin B
Eur J Surg Oncol; 2021 Aug; 47(8):1920-1927. PubMed ID: 33972144
[TBL] [Abstract][Full Text] [Related]
10. Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer.
Dong LF; Xu SY; Long JP; Wan F; Chen YD
J Int Med Res; 2018 Feb; 46(2):828-835. PubMed ID: 29441833
[TBL] [Abstract][Full Text] [Related]
11. Number of nodes in sentinel lymph node biopsy for breast cancer: Are surgeons still biased?
Percy DB; Pao JS; McKevitt E; Dingee C; Kuusk U; Warburton R
J Surg Oncol; 2018 Jun; 117(7):1487-1492. PubMed ID: 29484663
[TBL] [Abstract][Full Text] [Related]
12. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
[TBL] [Abstract][Full Text] [Related]
13. Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study.
de Boniface J; Frisell J; Bergkvist L; Andersson Y;
Br J Surg; 2017 Feb; 104(3):238-247. PubMed ID: 28052310
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
[TBL] [Abstract][Full Text] [Related]
15. Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer.
Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Lobbezoo DJ; Tjan-Heijnen VC; Voogd AC
Clin Breast Cancer; 2016 Aug; 16(4):e75-82. PubMed ID: 27116948
[TBL] [Abstract][Full Text] [Related]
16. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
18. Association of the number of sentinel lymph nodes harvested with survival in breast cancer.
Bonneau C; Bendifallah S; Reyal F; Rossi L; Rouzier R
Eur J Surg Oncol; 2015 Jan; 41(1):52-8. PubMed ID: 25466979
[TBL] [Abstract][Full Text] [Related]
19. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
Cabıoğlu N; Karanlık H; Kangal D; Özkurt E; Öner G; Sezen F; Yılmaz R; Tükenmez M; Önder S; İğci A; Özmen V; Dinççağ A; Engin G; Müslümanoğlu M
Ann Surg Oncol; 2018 Oct; 25(10):3030-3036. PubMed ID: 29978371
[TBL] [Abstract][Full Text] [Related]
20. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]